GlassScriptPhysician profile
Alyssa Jackson
NPI 1649895251
$503.07
in general payments reported to CMS, 2019-2025
16 companies · $98.01 in 2025
The $98.01 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $108 · 2022: $87.69 · 2023: $94.99 · 2024: $114 · 2025: $98.01.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $307.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $307.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cranial Technologies, INC | $53.96 | 2023-2025 | Doc Band |
| Astrazeneca Pharmaceuticals LP | $52.42 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $49.00 | 2021-2024 | Gardasil 9, Vaxelis, Vaxneuvance |
| Supernus Pharmaceuticals, INC. | $41.08 | 2023-2024 | Qelbree, Qelbree |
| Kowa Pharmaceuticals America, INC. | $41.06 | 2024-2025 | Zoryve |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $40.98 | 2021-2022 | |
| Sanofi Pasteur INC. | $40.72 | 2023-2024 | |
| Novo Nordisk INC | $40.47 | 2021-2022 | |
| Corium, LLC | $27.82 | 2024 | Azstarys |
| Ars Pharmaceuticals Operations, INC. | $22.93 | 2025 | Neffy |
| Pfizer INC. | $20.47 | 2024 | |
| Daiichi Sankyo INC. | $17.53 | 2022 | |
| Sanofi-Aventis U.S. LLC | $14.37 | 2025 | |
| Esperion Therapeutics, INC. | $14.07 | 2021 | |
| Glaxosmithkline, LLC. | $13.93 | 2025 | Bexsero, Rotarix |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $12.26 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alyssa Jackson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.